Current "legal highs"

Journal of Emergency Medicine

Volumn 44, Issue 6, 2013, Pages 1108-1115

  Johnson, Lucas A ^a   Johnson, Rebecca L ^b   Portier, Ray Bernard ^c  

^a III Marine Expeditionary Force   (United States)

^b III Marine Logistics Group   (United States)

^c III Marine Logistics Group   (United States)

Author keywords

bath salts; cathinone derivatives; herbal high; MDPV; mephedrone; naphyrone; plant food; Salvia; Salvinorin A; Spice; synthetic cannabinoids; Vanilla Sky

Indexed keywords

4' METHYLMETHCATHINONE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; CANNABINOID DERIVATIVE; CANNABIS; CATHINONE; DEXANABINOL; OPIATE AGONIST; PSYCHOTROPIC AGENT; RECREATIONAL DRUG; SALVINORIN A; TETRAHYDROCANNABINOL;

ARTICLE; AWARENESS; CHEMICAL STRUCTURE; COGNITIVE DEFECT; DRUG ABUSE; DRUG CONTROL; DRUG TRAFFIC; EMERGENCY WARD; EUROPE; HUMAN; LAW; LAW ENFORCEMENT; PATIENT EDUCATION; POLICY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SALVIA DIVINORUM; SEXUAL AROUSAL; SPICE; UNITED STATES; VISUAL CORTEX;

BENZODIOXOLES; CANNABINOIDS; DESIGNER DRUGS; EMERGENCY MEDICINE; HUMANS; METHAMPHETAMINE; PENTANONES; PSYCHOTROPIC DRUGS; PYRROLIDINES; SALVIA; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84878572683     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2012.09.147     Document Type: Article

References (80)

1. R. Lindigkeit, A. Boehme, and I. Eiserloh Spice: a never ending story? Forensic Sci Int 191 2009 58 63
2. C. Mustata, M. Torrens, R. Pardo, C. Perez, and M. Farre Spice drugs: cannabinoids as a new designer drugs [Spanish] Adicciones 21 2009 181 186
3. R. Sedefov, A. Gallegos, and L. King Understanding the spice phenomenon 2009 European Monitoring Centere for Drugs and Drug Addiction Lisbon
4. Rose J. The unlikely Clemson chemist behind synthetic marijuana. WFAE; January 25, 2011. Available at: http://wfae.org/post/unlikely-clemson-chemist- behind-synthetic-marijuana-0. Accessed March 2, 2013.
5. Gordon E. Kansas moves to outlaw marijuana-mimicking incense. All Things Considered: NPR; 2010. Available at: http://www.npr.org/templates/story/story. php?storyId=124087307. Accessed March 2, 2013.
6. M.W. Savage The growing buzz on 'spice' - the marijuana alternative Washington Post 10 July 2010
7. Velardo M. Spice users showing up in hospitals across Michigan. Examiner.com. Available at: http://www.examiner.com/article/spice-users-showing- up-hospitals-across-michigan. Accessed March 18, 2013.
8. American Association of Poison Control Centers. Synthetic marijuana data: updated February 8, 2012. Available at: http://www.aapcc.org/alerts/synthetic- marijuana/. Accessed March 2, 2013.
9. Office of National Drug Control Policy 2011 Monitoring the Future study highlights 2011 Office of National Drug Control Policy Washington, DC
10. K.C. Chimalakonda, C.L. Moran, and P.D. Kennedy Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine Anal Chem 83 2011 6381 6388
11. J. Gould Officials cope with new drug craze Army Times 02 October 2010
12. G. McLachlan Taking the spice out of legal smoking mixtures Lancet 374 2009 600
13. J.W. Huffman, A.L. Thompson, J.L. Wiley, and B.R. Martin Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940 Bioorg Med Chem 16 2008 322 335
14. V. Auwarter, S. Dresen, W. Weinmann, M. Muller, M. Putz, and N. Ferreiros 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44 2009 832 837
15. H. Muller, W. Sperling, M. Kohrmann, H.B. Huttner, J. Kornhuber, and J.M. Maler The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes Schizophr Res 118 2010 309 310
16. U.S. Zimmermann, P.R. Winkelmann, M. Pilhatsch, J.A. Nees, R. Spanagel, and K. Schulz Withdrawal phenomena and dependence syndrome after the consumption of "spice gold" Dtsch Arztebl Int 106 2009 464 467
17. J. Simmons, L. Cookman, C. Kang, and C. Skinner Three cases of "spice" exposure Clin Toxicol (Phila) 49 2011 431 433
18. A. Mir, A. Obafemi, A. Young, and C. Kane Myocardial infarction associated with use of the synthetic cannabinoid K2 Pediatrics 128 2011 e1622 e1627
19. Office of Diversion Control, US Department of Justice. Drug Scheduling. 2010. Available at: http://www.justice.gov/dea/pubs/scheduling.html. Accessed December 21, 2010.
20. Synthetic cannabinoids legislation. 07 March 2012. Available at: http://www.ncsl.org/issues-research/justice/synthetic-cannabinoids-enactments. aspx. Accessed March 7, 2012.
21. Drug Enforcement Administration, Department of Justice Schedules of controlled substances: temporary placement of five synthetic cannabinoids into Schedule I Fed Regist 76 2011 11075 11078
22. Drug Enforcement Administration, Department of Justice Schedules of controlled substances: temporary placement of five synthetic cannabinoids into Schedule I Fed Regist 75 2010 71635 71638
23. J. Jouvenal 'Spice' makers alter recipes to sidestep state laws banning synthetic marijuana Washington Post 28 Dec 2011
24. Associated Press. Minn. head shop owner says fake pot ban won't work. MPRNEWS 01 March 2011. Available at: http://minnesota.publicradio.org/display/ web/2011/03/01/fake-pot. Accessed March 2, 2013.
25. T.E. Prisinzano Psychopharmacology of the hallucinogenic sage Salvia divinorum Life Sci 78 2005 527 531
26. A.S. Reisfield The botany of Salvia divinorum (labiatae) SIDA: Contributions to Botany 15 1993 349 366
27. R. Vohra, A. Seefeld, F.L. Cantrell, and R.F. Clark Salvia divinorum: exposures reported to a statewide poison control system over 10 years J Emerg Med 40 2011 643 650
28. L.J. Valdes 3rd, J.L. Diaz, and A.G. Paul Ethnopharmacology of ska Maria Pastora (Salvia divinorum, Epling and Jativa-M.) J Ethnopharmacol 7 1983 287 312
29. InfoFacts: Salvia. National Institute of Drug Abuse, December 2009. Available at: http://www.drugabuse.gov/publications/infofacts/salvia. Accessed March 7, 2012.
30. M. Imanshahidi, and H. Hosseinzadeh The pharmacological effects of Salvia species on the central nervous system Phytother Res 20 2006 427 437
31. V. Hoover, D.B. Marlowe, N.S. Patapis, D.S. Festinger, and R.F. Forman Internet access to Salvia divinorum: implications for policy, prevention, and treatment J Subst Abuse Treat 35 2008 22 27
32. H.R. Sumnall, F. Measham, S.D. Brandt, and J.C. Cole Salvia divinorum use and phenomenology: results from an online survey J Psychopharmacol 25 2011 1496 1507
33. Y. Zhang, E.R. Butelman, S.D. Schlussman, A. Ho, and M.J. Kreek Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors Psychopharmacology (Berl) 179 2005 551 558
34. K. Tsujikawa, K. Kuwayama, and H. Miyaguchi Determination of salvinorin A and salvinorin B in Salvia divinorum-related products circulated in Japan Forensic Sci Int 180 2008 105 109
35. Finnstrom K. Salvia fears. CNN; 27 April 2008. Available at: http://www.cnn.com/video/#/video/us/2008/04/27/finnstrom.salvia.fears.cnn. Accessed March 2, 2013.
36. Substance Abuse and Mental Health Services Administration Use of specific hallucinogens: 2006. The NSDUH report, February 14, 2008 2008 Office of Applied Studies, Substance Abuse and Mental Health Services Administration Rockville, MD
37. J.E. Lange, M.B. Reed, J.M. Croff, and J.D. Clapp College student use of Salvia divinorum Drug Alcohol Depend 94 2008 263 266
38. M.J. Baggott, E. Erowid, F. Erowid, G.P. Galloway, and J. Mendelson Use patterns and self-reported effects of Salvia divinorum: an internet-based survey Drug Alcohol Depend 111 2010 250 256
39. J.E. Lange, J. Daniel, K. Homer, M.B. Reed, and J.D. Clapp Salvia divinorum: effects and use among YouTube users Drug Alcohol Depend 108 2010 138 140
40. J.M. Hooker, Y. Xu, W. Schiffer, C. Shea, P. Carter, and J.S. Fowler Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans Neuroimage 41 2008 1044 1050
41. M. Baggott, E. Erowid, and F. Erowid A survey of Salvia divinorum users Erowid Extracts 2004 12 14
42. M. Mowry, M. Mosher, and W. Briner Acute physiologic and chronic histologic changes in rats and mice exposed to the unique hallucinogen salvinorin A J Psychoactive Drugs 35 2003 379 382
43. Siebert D. Open letter to lawmakers re: regulation of Salvia divinorum. Malibu, CA: www.sagewisdom.org; 23 March 2009:3.
44. Salvia: legal but lethal. CNN, 13 April 2006. Available at: http://www.transcripts.cnn.com/TRANSCRIPTS/0604/13/lol.03.html. Accessed January 11, 2010.
45. US Department of Justice. Salvia divinorum. Available at: http://www.justice.gov/dea/concern/salvia-divinorum.html. Accessed March 7, 2012.
46. D. James, R.D. Adams, and R. Spears Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service Emerg Med J 28 2011 686 689
47. P. Kalix Pharmacological properties of the stimulant khat Pharmacol Ther 48 1990 397 416
48. P. Kalix Cathinone, a natural amphetamine Pharmacol Toxicol 70 1992 77 86
49. F. Schifano, A. Albanese, and S. Fergus Mephedrone (4- methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues Psychopharmacology (Berl) 214 2011 593 602
50. Urquhart C. Drugs and dance as Israelis blot out intifada. Guardian 4 September 2004. Available at: http://www.guardian.co.uk/world/2004/sep/04/ israel. Accessed March 2, 2013.
51. A.R. Winstock, L.R. Mitcheson, P. Deluca, Z. Davey, O. Corazza, and F. Schifano Mephedrone, new kid for the chop? Addiction 106 2011 154 161
52. T.M. Brunt, A. Poortman, R.J. Niesink, and W. van den Brink Instability of the ecstasy market and a new kid on the block: mephedrone J Psychopharmacol 25 2011 1543 1547
53. H. Sumnall, and O. Wooding Mephedrone: an update on current knowledge 2010 Centre for Public Health, Liverpool John Moores University Liverpool, UK
54. Psychonaut WebMapping Research Group Mephedrone report 2009 Institute of Psychiatry, King's College London London
55. P.I. Dargan, S. Albert, and D.M. Wood Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change QJM 103 2010 875 879
56. American Association of Poison Control Centers. Bath salts data: Updated November 3, 2011. Available at: http://www.aapcc.org/alerts/bath-salts/. Accessed March 2, 2013.
57. A.R. Winstock, J. Marsden, and L. Mitcheson What should be done about mephedrone? BMJ 340 2010 c1605
58. S. Gibbons, and M. Zloh An analysis of the 'legal high' mephedrone Bioorg Med Chem Lett 20 2010 4135 4139
59. D.M. Wood, S.L. Greene, and P.I. Dargan Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone Emerg Med J 28 2011 280 282
60. E.M. Sammler, P.L. Foley, G.D. Lauder, S.J. Wilson, A.R. Goudie, and J.I. O'Riordan A harmless high? Lancet 376 2010 742
61. P.J. Nicholson, M.J. Quinn, and J.D. Dodd Headshop heartache: acute mephedrone 'meow' myocarditis Heart 96 2010 2051 2052
62. F. Westphal, T. Junge, P. Rosner, F. Sonnichsen, and F. Schuster Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure Forensic Sci Int 190 2009 1 8
63. Wikipedia. Pyrovalerone. Available at http://en.wikipedia.org/wiki/ Pyrovalerone. Accessed December 22, 2010.
64. McConnaughey J. Drugs disguised as bath salts send users to ERs. Associated Press; December 23, 2010. Available at: http://www.nbcnews.com/id/ 40797021/ns/health-addictions/#.UTJwVjCsiSo. Accessed March 2, 2013.
65. Erowid. MDPV effects. 11 Mar 2010. Available at: http://www.erowid.org/ chemicals/mdpv/mdpv-effects.shtml. Accessed December 18, 2010.
66. Psychonaut WebMapping Research Group MDPV report 2009 Institute of Psychiatry, King's College London London
67. L. Karila, and M. Reynaud GHB and synthetic cathinones: clinical effects and potential consequences Drug Test Anal 3 2011 552 559
68. North Yorkshire Police. Drugs warning as MDPV takes its toll on teenagers. 2010. Available at: http://www.northyorkshire.police.uk/index.aspx? articleid=4030. Accessed December 21, 2010.
69. Porter R. The bride killed by bath salts - the new 'legal high' Ivory Wave drug that's sweeping Britain. Daily Mail 28 August 2010. Available at: http://www.dailymail.co.uk/news/article-1306877/Legal-high-bath-salts-Ivory- Wave-kill-bride.html. Accessed March 2, 2013.
70. S. Frohlich, E. Lambe, and J. O'Dea Acute liver failure following recreational use of psychotropic "head shop" compounds Ir J Med Sci 180 2011 263 264
71. J.L. Antonowicz, A.K. Metzger, and S.L. Ramanujam Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases Gen Hosp Psychiatry 33 2011 640.e5 640.e6
72. J.J. Dorairaj, C. Healy, M. McMenamin, and P.A. Eadie The untold truth about "bath salt" highs: a case series demonstrating local tissue injury J Plast Reconstr Aesthet Surg 65 2012 e37 e41
73. T.M. Penders, and R. Gestring Hallucinatory delirium following use of MDPV: "bath salts" Gen Hosp Psychiatry 33 2011 525 526
74. G.S. Winder, N. Stern, and A. Hosanagar Are "bath salts" the next generation of stimulant abuse? J Subst Abuse Treat 44 2013 42 45
75. Drug Enforcement Administration Schedules of controlled substances: temporary placement of three synthetic cathinones into Schedule I Fed Regist 76 2011 65371 65375
76. C. Gregoire Bath salts as drugs: parents, health officials alarmed over rising number of teen overdoses Huffington Post 15 March 2012
77. Shute N. Woman injects 'bath salts,' loses arm to flesh-eating bacteria. Shots: Health News from NPR, National Public Radio; 13 January 2012. Available at: http://www.npr.org/blogs/health/2012/01/13/145179057/woman-injects-bath- salts-loses-arm-to-flesh-eating-bacteria. Accessed March 2, 2013.
78. L. Gussow Special report: coming soon to an ED near you: Bromo-Dragonfly (not an insect), K2 (not a mountain), and Venus (not the planet) Emerg Med News 32 2010 20 21
79. S.D. Brandt, H.R. Sumnall, F. Measham, and J. Cole Analyses of second-generation 'legal highs' in the UK: initial findings Drug Test Anal 2 2010 377 382
80. S.D. Brandt, H.R. Sumnall, F. Measham, and J. Cole Second generation mephedrone. The confusing case of NRG-1 BMJ 341 2010 c3564